The effect of detergent-based decellularization procedures on cellular proteins and immunogenicity in equine carotid artery grafts

Biomaterials

Volumn 32, Issue 36, 2011, Pages 9730-9737

  Böer, Ulrike ^a,b   Lohrenz, Andrea ^a   Klingenberg, Melanie ^a,b   Pich, Andreas ^b   Haverich, Axel ^a,b   Wilhelmi, Mathias ^a,b  

^a GMP Model Lab for Tissue Engineering   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Decellularization; Extracellular matrix; Immune response; Mass spectrometry; Westernblot

Indexed keywords

ALLOPLASTIC MATERIALS; AQUEOUS MATRICES; CAROTID ARTERY; CELLULAR COMPONENTS; CELLULAR PROTEINS; CYTOSOLIC; CYTOSOLS; DECELLULARIZATION; DECELLULARIZED; DETERGENT CONCENTRATIONS; DNA CONTENT; DNA QUANTIFICATION; DRY WEIGHT; ENDONUCLEASES; EXTRACELLULAR MATRICES; IMMUNE RESPONSE; IMMUNOGENICITY; IN-VIVO; MATRIX; SMOOTH MUSCLE ACTINS; WESTERN-BLOT ANALYSIS; WESTERNBLOT;

CELL MEMBRANES; CYTOLOGY; DETERGENTS; DNA; ENZYME ACTIVITY; MAMMALS; MASS SPECTROMETRY; SOLVENT EXTRACTION; TISSUE;

PROTEINS;

CELL PROTEIN; CYTOSKELETON PROTEIN; DETERGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SMOOTH MUSCLE ACTIN;

ANTIBODY PRODUCTION; ARTERY GRAFT; ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CELL ORGANELLE; CYTOSOL; DECELLULARIZED EQUINE CAROTID ARTERY; DETERGENT BASED DECELLULARIZATION PROCEDURE; DNA CONTENT; IMMUNOGENICITY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; WESTERN BLOTTING;

ACTINS; ALPHA-GALACTOSIDASE; ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; BLOOD VESSEL PROSTHESIS; CAROTID ARTERIES; CELL EXTRACTS; DETERGENTS; EPITOPES; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (PHOSPHORYLATING); HISTOCOMPATIBILITY ANTIGENS CLASS I; HORSES; IMMUNIZATION; MASS SPECTROMETRY; MICE; MUSCLE, SMOOTH; PROTEINS; TISSUE ENGINEERING;

EQUIDAE; MUS;

EID: 80054074735     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.09.015     Document Type: Article

References (31)

1. Crapo P.M., Gilbert T.W., Badylak S.F. An overview of tissue and whole organ decellularization processes. Biomaterials 2011, 32:3233-3243.
2. Badylak S.F., Gilbert T.W. Immune response to biologic scaffold materials. Semin Immunol 2008, 20(2):109-116.
3. Gilbert T.W., Sellaro T.L., Badylak S.F. Dezellularization of tissues and organs. Biomaterials 2006, 27(19):3675-3683.
4. Rizzi S.C., Upton Z., Bott K., Dargaville T.R. Recent advances in dermal wound healing: biomedical device approaches. Expert Rev Med Devices 2010, 7(1):143-154.
5. Knight R.L., Wilcox H.E., Korossis S.A., Fisher J., Ingham E. The use of acellular matrices for the tissue engineering of cardiac valves. Proc Inst Mech Eng H 2008, 222(1):129-143.
6. Bejjani G.K., Zabramski J. Durasis Study Group. Safety and efficacy of the porcine small intestinal submucosa dural substitute: results of a prospective multicenter study and literature review. J Neurosurg 2007, 106(6):1028-1033.
7. Simon P., Kasimir M.T., Seebacher G., Weigel G., Ullrich R., Salzer-Muhar U., et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT™ in pediatric patients. Eur J Cardiothorac Surg 2003, 23:1002-1006.
8. Rüffer A., Purbojo A., Cicha I., Glöckler M., Potapov S., Dittrich S., et al. Early failure of xenogenous de-cellularised pulmonary valve conduits - a word of caution. Eur J Cardiothorac Surg 2010, 38:78-85.
9. Gilbert T.W., Freund J.M., Badylak S.F. Quantification of DNA in biologic scaffold materials. J Surg Res 2009, 152(1):135-139.
10. Lotze M.T., Deisseroth A., Rubartelli A. Damage associated molecular pattern molecules. Clin Immunol 2007, 124:1-4.
11. Nagata S., Hanayama R., Kawane K. Autoimmunity and the clearance of dead cells. Cell 2010, 140:619-630.
12. Galili Uri Immune response, accomodation and tolerance to transplantation carbohydrate antigens. Transplantation 2004, 78(8):1093-1098.
13. Kasimir M.T., Rieder E., Seebacher G., Wolner E., Weigel G., Simon P. Presence and elimination of the xenoantigen Gal (α1,3) Gal in tissue-engineered heart valves. Tissue Eng 2005, 11(7/8):1274-1280.
14. Macher B.A., Galili U. The Galα1,3Galβ1,4GlcNAc-R (α-Gal) epitope: a carbohydrate of unique evolution and clinical relevance. Biochim Biophys Acta 2008, 1780(2):75-88.
15. Daly K.A., Stewart-Akers A.M., Hara H., Ezzelarab M., Long C., Cordero K., et al. Effect of the αGal epitope on the response to small intestinal submucosa extracellular matrix in a nonhuman primate model. Tissue Eng Part A 2009, 15(12):3877-3888.
16. Wilhelmi M., Haverich A. Materials used for hemodialysis vascular access: current strategies and a call to action. Graft 2003, 6(1):6-15.
17. Zheng M.H., Chen J., Kirilak Y., Willers C., Xu J., Wood D. Porcine small intestine submucosea (SIS) is not an acellular collagenous matrix and contains porcine DNA: possible implications in human implantation. J Biomed Mater Res B Appl Biomater 2005, 73:61-67.
18. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., et al. Circulating mitochondrial DMAPs cause imflammatory responses to injury. Nature 2010, 464(7285):104-107.
19. Brown B.N., Valentin J.E., Stewart-Akers A.M., McCabe G.P., Badylak S.F. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 2009, 30:1482-1491.
20. Lichtenberg A., Tudorache I., Cebotari S., Supronov M., Tudorache G., Goerler H., et al. Preclinical testing of tissue-engineered heart valves re-endothelialized under stimulated physiological conditions. Circulation 2006, 114(1):I559-I565.
21. Baraki H., Tudorache I., Braun M., Höffler K., Görler A., Lichtenberg A., et al. Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model. Biomaterials 2009, 30:6240-6246.
22. Bär A., Dorfmann S.E., Fischer P., Hilfiker-Kleiner D., Cebotari S., Tudorache I., et al. The pro-angiogenic factor CCN1 enhances the re-endothelialization of biological vascularized matrices in vitro. Cardiovasc Res 2010, 85:806-813.
23. Cebotari S., Tudorache I., Jaekel T., Hilfiker A., Dorfmann S., Ternes W., et al. Detergent decellularization of heart valves for tissue engineering: toxicological effects of residual detergents on human endothelial cells. Artif Organs 2010, 34(3):206-210.
24. Naso F., Gandaglia A., Iop L., Spina M., Gerosa G. First quantitative assay of alpha-Gal in soft tissues: presence and distribution of the epitope before and after cell removal from xenogeneic heart valves. Acta Biomater 2011, 7(4):1728-1734.
25. Stapleton T.W., Ingram J., Katta J., Knight R., Korossis S., Fisher J., et al. Development and characterization of an acellular porcine meniscus for use in tissue engineering. Tissue Eng 2008, 14(4):505-518.
26. Xu H., Wan H., Zuo W., Sun W., Owens R.T., Harper J.R., et al. A porcine-derived acellular dermal scaffold that supports soft tissue regeneration: removal of terminal galacotose-a-(1,3)-galcatose and retention of matrix structure. Tissue Eng Part A 2009, 15(7):1807-1819.
27. Gonçalves A.C., Griffiths L.G., Anthony R.V., Orton E.C. Decellularization of bovine pericardium for tissue-engineering by targeted removal of xenoantigens. J Heart Valve Dis 2005, 14(2):212-217.
28. Griffiths L.G., Choe L., Lee K.H., Reardon K.F., Orton C.E. Protein extraction and 2-DE of water-and lipid-soluble proteins from bovine pericardium, a low-cellularity tissue. Electrophoresis 2008, 29:4508-4515.
29. Allman A.J., McPherson T.B., Badylak S.F., Merrill L.C., Kallakury B., Sheehan C., et al. Xenogeneic extracellular matrix grafts elicit a Th2-restricted immune response. Transplantation 2001, 71(11):1631-1640.
30. Könneker S., Teebken O.E., Bonhie M., Pflaum M., Jockenhoevel S., Haverich A., et al. A biologicial alternative to alloplastic grafts in dialysis therapy: evaluation of an autologised bioartificial haemodialysis shunt vessel in a sheep model. Eur J Vasc Endovasc Surg 2010, 40(6):810-816.
31. Cebotari S., Breymann T., Tudorache I., Boethig D., Sarikouch S., Goerler A., et al. The use of fresh decellularized allografts for pulmonary valve replacement reduces the reoperation rate in children and young adults 2011, Accepted by Circulation.